Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Sine Pharmaceutical is a large Chinese pharmaceutical manufacturer within the Shanghai Pharmaceuticals group focused primarily on commercialized prescription medicines and specialty formulations. The company has a broad portfolio spanning chemical drugs, probiotics or microecological products, and selected biologic products, with strengths in dosage-form breadth and established domestic manufacturing scale. Publicly available pipeline intelligence indicates activity across endocrine and metabolic disease, oncology, neurology, immunology, infectious disease, and hematology, with most programs centered on small molecules. The company also operates R&D capabilities in microecology, inhalation and other specialty drug-device or formulation technologies, and innovative chemical formulations. Overall, it appears to be a mature commercial pharma company rather than a venture-stage biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sine.